These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21112752)

  • 61. Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic Drug Metabolism.
    Wahlang B; Falkner KC; Cave MC; Prough RA
    Adv Pharmacol; 2015; 74():1-33. PubMed ID: 26233902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Insights into drug metabolism from modelling studies of cytochrome P450-drug interactions.
    Maréchal JD; Sutcliffe MJ
    Curr Top Med Chem; 2006; 6(15):1619-26. PubMed ID: 16918473
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice.
    Renaud HJ; Cui JY; Khan M; Klaassen CD
    Toxicol Sci; 2011 Dec; 124(2):261-77. PubMed ID: 21920951
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug-metabolizing cytochrome P450s in the brain.
    Miksys SL; Tyndale RF
    J Psychiatry Neurosci; 2002 Nov; 27(6):406-15. PubMed ID: 12491573
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction.
    Almond LM; Yang J; Jamei M; Tucker GT; Rostami-Hodjegan A
    Curr Drug Metab; 2009 May; 10(4):420-32. PubMed ID: 19519348
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them.
    Guo Z; Johnson V; Barrera J; Porras M; Hinojosa D; Hernández I; McGarrah P; Potter DA
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):409-423. PubMed ID: 30066055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acyclic nucleoside phosphonates: a study on cytochrome P450 gene expression.
    Nekvindova J; Contreras JA; Juvan P; Fon Tacer K; Anzenbacher P; Zidek Z; Kopecna Zapletalova M; Rozman D; Anzenbacherova E
    Xenobiotica; 2014 Aug; 44(8):708-15. PubMed ID: 24593268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in the expression of cytochrome P450 genes in hemin-induced differentiated K562 cells.
    Nagai F; Shimizu M; Sakamoto T; Kobayashi T; Tamura H
    Biol Pharm Bull; 2007 Oct; 30(10):1954-7. PubMed ID: 17917270
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of hypoxia on cytochrome P450 activity and expression.
    Fradette C; Du Souich P
    Curr Drug Metab; 2004 Jun; 5(3):257-71. PubMed ID: 15180495
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases.
    Korobkova EA
    Chem Res Toxicol; 2015 Jul; 28(7):1359-90. PubMed ID: 26042469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolic characterization of cell systems used in in vitro toxicology testing: lung cell system BEAS-2B as a working example.
    Garcia-Canton C; Minet E; Anadon A; Meredith C
    Toxicol In Vitro; 2013 Sep; 27(6):1719-27. PubMed ID: 23669205
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism.
    Bishop-Bailey D; Thomson S; Askari A; Faulkner A; Wheeler-Jones C
    Annu Rev Nutr; 2014; 34():261-79. PubMed ID: 24819323
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cyclamen Trochopteranthum: Cytotoxic activity and possible adverse interactions including drugs and carcinogens.
    Arslan S; Ozgun O
    Chin J Integr Med; 2012 Sep; ():. PubMed ID: 23001494
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays.
    Nguyen LT; Ramanathan M; Weinstock-Guttman B; Dole K; Miller C; Planter M; Patrick K; Brownscheidle C; Jacobs LD
    Drug Metab Dispos; 2000 Aug; 28(8):987-93. PubMed ID: 10901711
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 293FT is a highly suitable mammalian cell line for the in vitro enzymatic activity analysis of typical P450 proteins.
    Dai DP; Geng PW; Cai J; Wang SH; Nic JJ; Hu JH; Hu GX; Cai JP
    Pharmazie; 2015 Jan; 70(1):33-7. PubMed ID: 25975096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro inhibitory effects of pulvinic acid derivatives isolated from Chinese edible mushrooms, Boletus calopus and Suillus bovinus, on cytochrome P450 activity.
    Huang YT; Onose J; Abe N; Yoshikawa K
    Biosci Biotechnol Biochem; 2009 Apr; 73(4):855-60. PubMed ID: 19352038
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.
    Tanaka E
    J Clin Pharm Ther; 1999 Apr; 24(2):87-92. PubMed ID: 10380060
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro].
    Pawłowska M; Augustin E
    Postepy Hig Med Dosw (Online); 2011 Jun; 65():367-76. PubMed ID: 21734321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Availability of specific reductases controls the temporal activity of the cytochrome P450 complement of Streptomyces coelicolor A3(2).
    Lei L; Waterman MR; Fulco AJ; Kelly SL; Lamb DC
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):494-9. PubMed ID: 14704268
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Focus on the intermediate state: immature mRNA of cytochromes P450--methods and insights.
    Köhler CU; Roos PH
    Anal Bioanal Chem; 2008 Nov; 392(6):1109-22. PubMed ID: 18762920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.